0001520138-22-000362.txt : 20220816
0001520138-22-000362.hdr.sgml : 20220816
20220816171121
ACCESSION NUMBER: 0001520138-22-000362
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220816
DATE AS OF CHANGE: 20220816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PEIZER TERREN S
CENTRAL INDEX KEY: 0000904534
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39015
FILM NUMBER: 221171034
MAIL ADDRESS:
STREET 1: 11111 SANTA MONICABLVD STE.500
CITY: LOS ANGELES
STATE: CA
ZIP: 90025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOVIE INC.
CENTRAL INDEX KEY: 0001580149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462510769
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
BUSINESS PHONE: 775-888-3162
MAIL ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
FORMER COMPANY:
FORMER CONFORMED NAME: NANOANTIBIOTICS, INC.
DATE OF NAME CHANGE: 20130625
4
1
ownership.xml
X0306
4
2022-08-15
0
0001580149
BIOVIE INC.
BIVI
0000904534
PEIZER TERREN S
C/O ACUITAS GROUP HOLDINGS, LLC
120 COLORADO AVENUE, #230
SANTA MONICA
CA
90404
1
0
1
0
Common Stock
2022-08-15
4
A
0
3636364
1.65
A
23166210
I
By Acuitas
Warrants (right to buy)
1.82
2022-08-15
4
A
0
7272728
A
2022-08-15
2027-08-15
Common Stock
7272728
7272728
I
By Acuitas
On July 15, 2022, BioVie Inc. (the "Issuer") entered into a securities purchase agreement with Acuitas, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $6,000,000.60, (i) 3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.
Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.
/s/ Joanne Wendy Kim, Attorney-in-Fact
2022-08-16